The American Journal of Cardiology

JANUARY 17, 2025

Publication date: Available online 16 January 2025 Source: The American Journal of Cardiology Author(s): Ann Marie Navar, Batul Electricwala, Jasjit K. Multani, Zifan Zhou, Chi-Chang Chen, Barnabie C. Agatep, Allison A. Petrilla, Taylor T. Schwartz, Laetitia N'dri, Joaquim Cristino, Fatima Rodriguez

Medicare 40

Medicare Cardiovascular Disease Cholesterol 40

American College of Cardiology

DECEMBER 18, 2023

The top ACC news stories of 2023 included news about ACC's latest clinical documents, health policy news about the 2024 Medicare Physician Fee Schedule rule and new Global Burden of Cardiovascular Disease data published in JACC.

Medicare 46

Medicare Document Cardiovascular Disease Article 46

American College of Cardiology

FEBRUARY 1, 2025

Initiatives such as the World Health Organization's "Medication Without Harm" and the Centers for Medicare and Medicaid Services' (CMS) expanded quality measures aim to reduce preventable emergency visits and hospital admissions due to medication-related harm. All are members of ACC’s Cardiovascular Team Member Section.

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease CMS Hospital 40

DAIC

JUNE 18, 2024

We look forward to working with FDA, Centers for Medicare & Medicaid Services, and respective physician societies to bring this technology t­­o U.S. patients as soon as possible to elevate the standard of care for cardiovascular disease treatment.” “The

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

DAIC

JUNE 12, 2024

Impacting 25 million people globally [1], deep venous disease results from venous thromboembolism, a condition that occurs when a blood clot forms in the vein [2]. It is the third most common cardiovascular disease [2]. Deep venous anatomy and obstructions can present a multitude of complexities and mechanical challenges.

Stent 105

Stent Stents Anatomy Ultrasound 105

Stroke Journal

FEBRUARY 1, 2024

We determined the utility of this score for predicting outcomes within one-year post-stroke/TIA.Methods:Analysis of adults with acute stroke/TIA (2012-2016) using linked data from the Australian Stroke Clinical Registry and administrative datasets (pharmaceutical, hospital, Medicare), as part of the PRECISE study.

Stroke 40

Stroke Strokes Outcomes Quality of Life 40

DAIC

MARCH 28, 2025

v As cardiovascular disease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. CCTA offers a non-invasive, cost-effective, and highly sensitive method for diagnosing coronary artery disease (CAD), making it a valuable tool for clinicians.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

DAIC

DECEMBER 5, 2024

This funding will allow us to expand our commercial reach, which is especially germane following our recent achievements in attaining Medicare coverage and a CPT Category I code for advanced plaque analysis. Barclay continued, “Cardiovascular disease is the #1 cause of death globally and costs our country $422B annually.

Coronary Artery Disease 52

Coronary Artery Disease Medicare Plaque Technology 52

CardiacWire

FEBRUARY 5, 2025

People aged 75 years make up ~65% of all deaths linked to cardiovascular disease, with age being one of the primary risk factors for ASCVD. With evolocumab now covered under Medicare, the drugs once $600 list price isnt what most patients are paying for it. At least insurance isnt an issue.

Medicare 59

Medicare Risk Factors Cardiovascular Disease Hospital 59

DAIC

OCTOBER 15, 2024

15, 2024 – Elucid has announced that four of the seven Medicare Administrative Contractors (MACs) will extend coverage for AI-enabled quantitative coronary plaque analysis, including its FDA-cleared PlaqueIQ image analysis software, beginning Nov. In the United States, one person dies every 33 seconds from cardiovascular disease.

Medicare 52

Medicare Plaque Chest Pain Coronary Artery Disease 52

DAIC

APRIL 24, 2024

CVD is especially prevalent in the Medicare-aged population, affecting more than 75 percent of those aged 60-79 and more than 90 percent of those aged 80 and over. Eighty percent of heart attacks and strokes are preventable. Yet, CVD remains the leading cause of death in the U.S., Yet, CVD remains the leading cause of death in the U.S.,

Blood Pressure 116

Blood Pressure Cholesterol Technology Heart Attack 116

DAIC

JULY 18, 2024

CPT codes are widely used by government payers, including Medicare and Medicaid, and commercial insurance companies to identify healthcare services and procedures for reimbursement. In accordance with the AMA semi-annual early release schedule, the new codes will be effective January 1st, 2025 and published in the 2025 CPT Code book.

Reimbursement 105

Reimbursement Technology Electrocardiogram Medicaid 105

Journal of the American Heart Association

MARCH 21, 2025

However, the association of socioeconomic vulnerability and outcomes after hospitalization is uncertain.Methods and ResultsAmerican Heart Association COVID19 Cardiovascular Disease Registry hospitalizations between March 1, 2020, and June 30, 2022, linked with Medicare feeforservice claims, were analyzed.

COVID-19 40

COVID-19 Medicare Cardiogenic Shock Hospital 40

The Beat Blog

MARCH 30, 2022

Cardiovascular diseases (CVD) affect nearly half of all American adults, and in addition to their impact on health outcomes, they have significant economic implications. are associated with these conditions, the largest across all disease categories. 17% of all annual healthcare costs in the U.S.

Blood Pressure 52

Blood Pressure Diabetes Risk Factors Cardiovascular Disease 52

Stroke Journal

JANUARY 30, 2025

As younger stroke survivors live longer, access to healthcare is essential for the detection, treatment, and monitoring of cardiovascular disease (CVD) risk factors to prevent recurrent stroke or other acute CVD events.

Risk Factors 40

Risk Factors Stroke Strokes Education 40

DAIC

MAY 16, 2024

PAD is a serious, progressive cardiovascular disease primarily caused by a buildup of fatty plaque in the blood vessels, or atherosclerosis. This plaque narrows the blood vessels and reduces blood flow to the legs and feet, which may significantly impair physical function, walking performance and quality of life.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

Cardiomatics

FEBRUARY 9, 2022

The World Health Organization reports that cardiovascular disease is the leading cause of death worldwide [1]. One of these diseases is heart failure – a condition in which the heart is unable to pump enough blood to the organs in our body. Heart Fail. 2012, 14, 628–634. [5] 5] Bilchick, K.C.; 6] Howell, S.J.;

Heart Failure 52

Heart Failure Myocardial Infarction Medicare Defibrillator 52

Dr. S. Venkatesan MD

JANUARY 1, 2025

Top 10 Clinical Trials Preventive PCI on Stenosis With Functionally Insignificant Vulnerable Plaque PREVENT (ACC.24) 24) Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With HF FINEARTS-HF (ESC Congress 2024 and AHA 2024) Randomized Evaluation of Decreased Usage of Beta-Blockers After AMI REDUCE-AMI (ACC.24)

Cardiogenic Shock 59

Cardiogenic Shock Plaque Academic Bicuspid/Mitral 59

The Beat Blog

AUGUST 12, 2022

Elliott Fisher during a 2006 public meeting with the Medicare Payment Advisory Committee (MedPAC). Then, six years later in 2012, The Patient Protection and Affordable Care Act (ACA) authorized the use of Accountable Care Organizations (ACOs) to improve the safety and quality of care and reduce health care costs in Medicare.

Medicare 52

Medicare Nursing Health Disparities Cardiovascular Disease 52